Sept 10 (Reuters) - Recce Pharmaceuticals Ltd RCE.AX :
* RECCE PHARMACEUTICALS ANNOUNCES POSITIVE & CONCENTRATION-DEPENDENT EFFICACY OF RECCE® COMPOUNDS AGAINST COVID-19 IN INTERNATIONAL STUDY
* RECCE PHARMACEUTICALS - R327, R529 COMPOUNDS SHOW CONCENTRATION-DEPENDENT FALL IN COVID-19 IN-VITRO STUDY USING ORGANOIDS MADE FROM HUMAN AIRWAY EPITHELIAL CELLS
* RECCE PHARMACEUTICALS - CONCENTRATIONS OF R327, R529 TESTED, FURTHER INDICATED EXCELLENT TOXICITY PROFILE ON VERO CELLS, IN SEPARATE BUT RELATED STUDY